+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07485569

Personalized Network Pharmacology-Based Drug Repurposing for Advanced Thyroid Cancer A Pilot Feasibility Trial

Led by Radboud University Medical Center · Updated on 2026-10-28

10

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

This clinical trial focuses on patients with advanced thyroid cancer who have no remaining standard treatment options. It explores a personalized drug repurposing approach using network pharmacology, where drug combinations are selected based on the unique genetic profile of each patients tumor. The study aims to assess whether giving individualized drug combinations is feasible and to evaluate the safety and tumor control potential of these treatments. Participants undergo tumor molecular profiling to identify personalized treatment plans using approved drugs administered at authorized doses. This is a single-arm, phase Ib trial lasting about four months. The first month is dedicated to tumor examination and treatment selection, followed by three months of treatment where patients receive their personalized drug combinations. Treatment regimens vary depending on the tumor genetics of each patient. Throughout the treatment period, participants have regular check-ups including blood tests, scans, and questionnaires to monitor safety and evaluate how well the treatment controls tumor growth. The primary outcomes focus on feasibility and safety over 12 weeks, with preliminary efficacy also assessed. The trial is sponsored by Radboud University Medical Center and funded by the EU Horizon REPO4EU project.

CONDITIONS

Brief Title

Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

Research Team

R

R Netea-Maier, Prof. Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here